公司資料
Endra 股價、新聞與催化劑
- 股票代碼:
- NDRA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
4.49 USD (+0.45%)
收盤價
最後更新: 2026年8月17日
9.32M USD
市值
股價為何變動
As of Aug 17, 2026, NDRA closed up 0.45% at $4.49. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Endra was a medical technology company focused on thermo-acoustic imaging and diagnostic applications. Its business was aimed at noninvasive imaging rather than therapeutics.
所在地與產業分類
Endra was headquartered in the United States and listed on NASDAQ. It sat in medical devices and imaging technology rather than biotechnology.
商業模式特徵
The company depended on product validation, adoption, and the ability to prove its imaging platform had a practical market. Investors watched clearances, commercialization, and capital efficiency.
生技產業定位
Endra belongs in the imaging-device layer of healthcare. It is not biotech, but it is part of the broader diagnostics infrastructure where noninvasive technology matters.
未來催化劑
- Endra’s catalysts are Thermo-Acoustic Enhanced Ultrasound platform updates and any commercialization step that shows the company can still gain traction. The market will care about whether the technology can become practical.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。